SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$133,000
-58.0%
44,346
-62.9%
0.00%
-62.5%
Q4 2021$317,000
+42.2%
119,646
+94.4%
0.01%
+100.0%
Q3 2021$223,000
+156.3%
61,550
+206.2%
0.00%
+100.0%
Q2 2021$87,00020,1000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders